Therefore, in this study, we aimed to examine the bile acid metabolism of patients with postmenopausal osteoporosis by evaluating the levels of total bile acid and fibroblast growth factor 19 (FGF19). The gene discussed is FGF19; the disease is postmenopausal osteoporosis.